Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
First moderate complexity molecular test for sexually transmitted infections on fully automated, high throughput platform
Broad set of urogenital sample claims ensure greatest flexibility for patient access
New test for most common sexually transmitt... Diagnostics, FDA Roche Group, cobas, cobas CT/NG, chlamydia, gonorrhoeae
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news